Literature DB >> 2458939

Angiotensin-converting enzyme inhibition, cough and the serum concentration of substance P.

H Thysell1, K E Andersson, S I Andersson, R Ekman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2458939     DOI： 10.1007/bf00615232

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  9 in total

Review 1.  The neuropharmacology of capsaicin: review of some recent observations.

Authors:  S H Buck; T F Burks
Journal:  Pharmacol Rev       Date:  1986-09       Impact factor: 25.468

2.  Sulindac and cough induced by converting enzyme inhibitors.

Authors:  M G Nicholls; N L Gilchrist
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

3.  Enalapril-induced cough.

Authors:  D Webb; N Benjamin; J Collier; B Robinson
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

4.  Increased cough reflex associated with angiotensin converting enzyme inhibitor cough.

Authors:  R W Fuller; N B Choudry
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

5.  Cough associated with the use of captopril.

Authors:  S Sesoko; Y Kaneko
Journal:  Arch Intern Med       Date:  1985-08

6.  Hydrolysis of substance P and its analogs by angiotensin-converting enzyme from rat lung. Characterization of endopeptidase activity of the enzyme.

Authors:  H Yokosawa; S Endo; Y Ohgaki; J Maeyama; S Ishii
Journal:  J Biochem       Date:  1985-11       Impact factor: 3.387

7.  Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.

Authors:  E Theodorsson-Norheim; I Norheim; K Oberg; E Brodin; J M Lundberg; K Tatemoto; P G Lindgren
Journal:  Biochem Biophys Res Commun       Date:  1985-08-30       Impact factor: 3.575

8.  Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.

Authors:  M A Cascieri; H G Bull; R A Mumford; A A Patchett; N A Thornberry; T Liang
Journal:  Mol Pharmacol       Date:  1984-03       Impact factor: 4.436

9.  Angiotensin-converting enzyme and the cough reflex.

Authors:  A H Morice; R Lowry; M J Brown; T Higenbottam
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321
  9 in total
  5 in total

Review 1.  ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management.

Authors:  A Overlack
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 2.  Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

3.  Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-P.

Authors:  W W Yeo; I G Chadwick; M Kraskiewicz; P R Jackson; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

4.  Chronopharmacology of enalapril in hypertensive patients.

Authors:  K Sunaga; A Fujimura; T Shiga; A Ebihara
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Effects of glycopyrrolate on capsaicin-induced cough in normal volunteers treated with captopril.

Authors:  M van Wyk; D K Sommers; J R Snyman
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.